References
- Walker M et al. Core Curriculum for Lactation Consultant Practice(2nd edition). Jones&Bartlett. 2006:333-64.
- 전병선. 고려인삼의 유통 현황과 명품화 제품 개발 전략. Food Preservation and Processing Industry. 2009;8(2) :47-51.
- Hale T. Medications and Mother's Milk(14th edition). Amarillo:Pharmasoft Publishing. 2010:13-20.
- Seely D et al. Safety and Efficacy of Panax Ginseng during Pregnancy and Lactation. Can J Clin Parmacol. 2008 ;15(1):e87-e94.
- Wiklund IK et al. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Int J Clin Pharmacol Res. 1999;19 :89-99.
- Greenspan EM. Ginseng and vaginal bleeding[letter]. JAMA. 1983;249:2018. https://doi.org/10.1001/jama.249.15.2018
- Punnonen R, Lukola A. Oestrogenlike effect of ginseng. Br Med J. 1980;281:1110. https://doi.org/10.1136/bmj.281.6248.1110
- Cheng TO. Ginseng-Warfarin interaction. ACC Current Journal Review. 2000 ;9(1):84. https://doi.org/10.1016/S1062-1458(99)00042-2
- Siegel RK. Ginseng abuse syndrome: problems with panacea. JAMA 1979; 241(15):1614-5. https://doi.org/10.1001/jama.241.15.1614
- 식품의약품안전청. 건강기능식품에 사용할 수 없는 원료 등에 관한 규정 일부개정고시 42. 2008.
- 보건복지부. 기존한약서(보건사회부 예규 제233호, 1969)에 대한 잠정규정 개정. 2008.
- 兪孝通, 盧重禮, 朴允德. 새천년 鄕藥集成方. 서울:정담출판사. 2000:3-953.
- 李梃. 醫學入門. 서울:고려의학. 1998 :48-605.
- 許浚. 原本東醫寶鑑. 서울:남산당. 1996:72-671.
- 張景岳. 景岳全書. 서울:대성문화사. 1997:(上)4-765, (下)1-887.
- 龔廷賢. 壽世保元. 北京:人民衛生出版社. 1993:3-779.
- 康命吉. 濟衆新編. 서울:韓國醫學大系 18. 1992:93-630.
- 黃道淵. 對譯證脈․方藥合編. 서울: 남산당. 2000:51-371.
- 한국한의학연구원. 한의학 지식정보자원 웹서비스(jisik.kiom.re.kr).
- 제중신편 원문 데이터베이스. 누리미디어. 2003.
- 방약합편 원문 데이터베이스. IBOOKPIA. 2002.
- 이선영 등. 수유부의 유선질환을 의미하는 한의학 용어 연구. 한의학연구원논문집. 2010;16(2):1-7.
- 미국 약전 천연물 DB. http://naturaldatabase.therapeuticresearch.com.
- Klein S, Rister R, Riggins C. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. The Americal Botanical Council. 1998.
- 남기열, 박종대. 인삼의 한의학적 및 현대임상적 측면에서의 복용량 검토. J Ginseng Res. 2000;24(2):99-105.
- 남기열. 고려인삼의 주요 효능과 그 임상적 응용. J Ginseng Res. 2002; 26(3):111-31. https://doi.org/10.5142/JGR.2002.26.3.111
- Kim SN et al. Simultaneous quantification of 14 ginsenosides in Panax ginseng C.A. Meyer (Korean red ginseng) by HPLC-ELSD and its application to quality control. Journal of Pharmaceutical and Biomedical Analysis. 2007;45(1) :164-70. https://doi.org/10.1016/j.jpba.2007.05.001
- 식품의약품 안전청. 건강기능식품의 기준 및 규격 일부개정고시 7호. 2010.
- Hwang YP, Jeong HG. Ginsenoside Rb1 protects against 6-hydroxydopamin -induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt /Nrf2-dependent pathway in human dopaminergic cells. Toxicol Appl Pharmacol. 2010;242(1):18-28. https://doi.org/10.1016/j.taap.2009.09.009
- Lau WS et al. Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERalpha pathway. J Steroid Biochem Mol Biol. 2008;108(1-2):64-71. https://doi.org/10.1016/j.jsbmb.2007.06.005
- Lau WS et al. Mitogen-activated protein kinase(MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer(MCF-7) cells. Br J Pharmacol. 2009;156(7):1136-46. https://doi.org/10.1111/j.1476-5381.2009.00123.x
- Leung KW et al. Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor. Br J Pharmacol. 2007;152(2):207-15. https://doi.org/10.1038/sj.bjp.0707359
- Papapetropoulos A. A ginseng-derived oestrogen receptor beta (ERbeta) agonist, Rb1 ginsenoside, attenuates capillary morphogenesis. Br J Pharmacol. 2007;152(2):172-4. https://doi.org/10.1038/sj.bjp.0707360
- 백덕우, 이서윤, 지형준. 인삼 Saponin이 Prolactin 분비에 미치는 효과. 생약학회지. 1978;9(1):33-9.